Yanyan Shen
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Discovery and characterization of YSA64, a RBM39 degrader with in vivo efficacy and potent cellular activity in pediatric Ewing sarcoma A673.
Journal: European journal of medicinal chemistry
Published: March 13, 2026
SYT4 Interacts with PSMC6 to Facilitate Malignant Progression in Gastric Carcinoma via Activating Wnt/β-catenin Signaling.
Journal: International journal of biological sciences
Published: June 01, 2025
Discovery of 2(1H)-Quinoxalinone Derivatives as Potent and Selective MAT2A Inhibitors for the Treatment of MTAP-Deficient Cancers.
Journal: Journal of medicinal chemistry
Published: January 06, 2025
Discovery, Optimization, and Evaluation of Novel Pyridin-2(1H)-one Analogues as Potent TRK Inhibitors for Cancer Treatment.
Journal: Journal of medicinal chemistry
Published: January 16, 2024
Amlodipine inhibits Synaptotagmin-4's oncogenic activity on gastric cancer proliferation by targeting calcium signaling.
Journal: Functional & integrative genomics
Published: January 15, 2024
Correction: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance.
Journal: Molecular cancer
Published: August 19, 2023
Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma.
Journal: Acta pharmaceutica Sinica. B
Published: May 14, 2023
Structural Optimization of Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors.
Journal: Journal of medicinal chemistry
Published: February 21, 2023
ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK.
Journal: Frontiers in pharmacology
Published: October 15, 2022
Development of a CT image analysis-based scoring system to differentiate gastric schwannomas from gastrointestinal stromal tumors.
Journal: Frontiers in oncology
Published: September 30, 2022
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Journal: Signal transduction and targeted therapy
Published: August 10, 2022
Last Updated: 09/26/2026